Updated Jun. 20, 2012 at 9:32 a.m.

Premium Lock Liquidia lands GSK deal worth 'up to several hundred million dollars'

Published: 2012-06-20 09:05:00
Updated: 2012-06-20 09:32:51

Nano particles at Liquidia. Nanoparticles displayed on a PC screen at Liquidia. Image 1 of 3 · Next Image…

Drug giant GlaxoSmithKline is taking an equity stake, providing research funding and paying cash up front for rights to drug candidates being developed by Triangle-based Liquidia Technologies, which focuses on nanotechnology....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll